TOMDF Archives

Todos Medical (TOMDF) Inks Transformative CBD Supply Deal After Hours

Todos Medical Inc. (OTCMKTS: TOMDF) announced yesterday a $50 million supply contract of Tollovid and CBD products to Nerd Hemp an AI...

607

Biotech

Todos Medical (TOMDF) The Ultimate Pandemic Stock

Monkeypox Following in COVID’s Footsteps: Possible Back-to-Back Pandemics Todos Medical (OTCMKTS: TOMDF) is the ultimate pandemic stock because they win no matter...

584

Biotech

Todos (TOMDF) Leapfrogs Applied DNA (APDN) and Leads in the MonkeyPox Testing Race

Doubles National MonkeyPox testing capacity Todos Medical Inc. (OTMKTS: TOMDF) announced the validation of its MonkeyPox lesion and saliva-based test. Other than...

512

1

Biotech

Monkeypox Stocks Heating Up the Charts: TOMDF APDN CODX

Investors are facing the sober reality of a twin pandemic, COVID-19, and monkeypox. It’s now clear that the government missed the opportunity...

745

1

Biotech

Veru’s (NASDAQ: VERU) Repurposed COVID-19 Drug Facing Uphill Battle for EUA

At first glance Veru, Inc.’s (NASDAQ: VERU) COVID-19 therapy phase 3 top line results were notable but their battle for an emergency...

1.6K

Biotech

Todos (OTCMKTS: TOMDF) CEO Nails NewsMax Interview With Critical Messages About the Pandemic

This Saturday Todos Medical’s (OTCMKTS: TOMDF) CEO set the stage for future international media exposure. This interview was powerful, gripping, and informative...

737

Biotech

Why Todos Medical (OTCMKTS: TOMDF) is Running Ahead of the Pack

Todos Medical (OTCMKTS: TOMDF) was a value play before it started running recently based on sound fundamental analysis, and now investors are...

578

Biotech

The 3CL Secret to Pfizer’s and Todos Medical’s Success

Pfizer’s (NYSE: PFE) PAXLOVID has risen to prominence as the top COVID-19 antiviral in the world. The speed at which they rose...

2.0K

Biotech

Atea Failure Leaves Todos Medical (TOMDF) Last Man Standing in Oral Antivirals

The big news circulating this week was of Atea Pharmaceuticals’ (NASDAQ: AVIR) COVID-19 antiviral clinical trial failure, which instantly plummeted the stock...